Is fibromyalgia an autoimmune disorder?

Autoimmune disease Fibromyalgia Nociplastic pain

Journal

Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 07 08 2023
accepted: 24 08 2023
pubmed: 28 8 2023
medline: 28 8 2023
entrez: 27 8 2023
Statut: aheadofprint

Résumé

Fibromyalgia (FM) is a multifactorial syndrome which includes not only widespread pain and stiffness, now recognized as major symptoms, but also numerous other somatic, emotional, and neuropsychic manifestation. The lack of specific validated biological and instrumental biomarkers has made FM a condition of unexplained medical significance, and its pathophysiology remains controversial and subject to debate. The current hypothesis regarding the pathogenesis of FM proposes that its development is influenced by various mechanism, including genetic predisposition, stressful life events, inflammatory processes, and cognitive-emotional factors. However, despite the extensive research conducted to date, the available data do not provide a clear understanding of the pathogenesis of FM. In this article, we report the opposing viewpoints of two leading experts who debate the question of whether FM is an autoimmune disease, based on scientific data regarding this condition. Both perspectives are discussed and the latest evidence on the pathophysiology of FM is reported to provide a comprehensive understanding of this complex syndrome.

Identifiants

pubmed: 37634681
pii: S1568-9972(23)00158-1
doi: 10.1016/j.autrev.2023.103424
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103424

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daniel Clauw (D)

Anesthesiology Department, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, USA.

Piercarlo Sarzi-Puttini (P)

Rheumatology Department, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milano, Italy; Rheumatology, Università Statale di Milano, Italy. Electronic address: piercarlo.sarziputtini@gmail.com.

Greta Pellegrino (G)

Rheumatology Department, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milano, Italy.

Yehuda Shoenfeld (Y)

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel; Reichman University, Herzelia 46101, Israel.

Classifications MeSH